Trial Profile
A Randomized, Double-Blind, Placebo and Positive-Controlled, Crossover Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs Plazomicin (Primary) ; Moxifloxacin
- Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia; Pyelonephritis; Urinary tract infections
- Focus Adverse reactions
- Sponsors Achaogen
- 22 Jan 2019 Results of pooled analysis assessing the population pharmacokinetics for Plazomicin from 7 studies :NCT00822978, NCT01034774,NCT01462136,NCT01514929,NCT01096849,NCT01970371 and NCT02486627 were published in the Antimicrobial Agents and Chemotherapy
- 08 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.